Skip to main content
# Title Department Research Year
291 Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV Department of Pharmaceutical Organic Chemistry 2021
292 Design, synthesis and mechanistic study of new 1,2,4-triazole derivatives as antimicrobial agents 2021
293 Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles Department of Pharmaceutics 2021
294 Synthesis, and biological evaluation of new series of pyrrol-2(3H)-one and pyridazin-3(2H)-one derivatives as tubulin polymerization inhibitors Department of Pharmaceutical Organic Chemistry 2021
295 GALA-Modified Lipid Nanoparticles for the Targeted Delivery of Plasmid DNA to the Lungs Department of Pharmaceutics 2021
296 Inversion Kinetics of Some E/Z 3-(Benzylidene)-2-Oxo-indoline Derivatives and Their In Silico CDK2 Docking Studies Department of Medicinal Chemistry 2021
297 Antibiofilm and antivirulence potential of silver nanoparticles against multidrug‐resistant Acinetobacter baumannii Department of Pharmaceutics 2021
298 Cytosolic aromatic dehydrogenase provides benzoic acid for xanthone biosynthesis in Hypericum Department of Pharmacognosy 2021
299 Untargeted Metabolomics Studies on Drug-Incubated Phragmites australis Profiles Department of Pharmacognosy 2021
300 Towards understanding of the interaction of certain carbapenems with protein via combined experimental and theoretical approach Department of Pharmaceutical Analytical Chemistry 2021